316 related articles for article (PubMed ID: 29394026)
1. Medicinal Chemistry of Gold Anticancer Metallodrugs.
Casini A; Sun RW; Ott I
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394026
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Metallodrugs that Target Proteins.
Sullivan MP; Holtkamp HU; Hartinger CG
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394032
[TBL] [Abstract][Full Text] [Related]
3. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
Tan SJ; Yan YK; Lee PP; Lim KH
Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
[TBL] [Abstract][Full Text] [Related]
4. Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.
Casini A; Hartinger C; Gabbiani C; Mini E; Dyson PJ; Keppler BK; Messori L
J Inorg Biochem; 2008 Mar; 102(3):564-75. PubMed ID: 18177942
[TBL] [Abstract][Full Text] [Related]
5. Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.
Jurgens S; Kuhn FE; Casini A
Curr Med Chem; 2018 Feb; 25(4):437-461. PubMed ID: 28554319
[TBL] [Abstract][Full Text] [Related]
6. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
Babak MV; Ang WH
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
[TBL] [Abstract][Full Text] [Related]
7. Metallointercalators and Metalloinsertors: Structural Requirements for DNA Recognition and Anticancer Activity.
Schatzschneider U
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394033
[TBL] [Abstract][Full Text] [Related]
8. Design of Ru-arene Complexes for Antitumor Drugs.
Su W; Li Y; Li P
Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
[TBL] [Abstract][Full Text] [Related]
9. Nucleic Acid Quadruplexes and Metallo-Drugs.
Vilar R
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394031
[TBL] [Abstract][Full Text] [Related]
10. Non-covalent Metallo-Drugs: Using Shape to Target DNA and RNA Junctions and Other Nucleic Acid Structures.
Cardo L; Hannon MJ
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394030
[TBL] [Abstract][Full Text] [Related]
11. Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics.
Hartinger CG; Phillips AD; Nazarov AA
Curr Top Med Chem; 2011; 11(21):2688-702. PubMed ID: 22039871
[TBL] [Abstract][Full Text] [Related]
12. Gold(III) complexes in medicinal chemistry.
Maia PI; Deflon VM; Abram U
Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
[TBL] [Abstract][Full Text] [Related]
13. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
Peacock AF; Sadler PJ
Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
[TBL] [Abstract][Full Text] [Related]
14. High mitochondrial accumulation of new gadolinium(III) agents within tumour cells.
Morrison DE; Aitken JB; de Jonge MD; Ioppolo JA; Harris HH; Rendina LM
Chem Commun (Camb); 2014 Mar; 50(18):2252-4. PubMed ID: 24352097
[TBL] [Abstract][Full Text] [Related]
15. Gallium Complexes as Anticancer Drugs.
Chitambar CR
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394029
[TBL] [Abstract][Full Text] [Related]
16. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.
Bertrand B; Casini A
Dalton Trans; 2014 Mar; 43(11):4209-19. PubMed ID: 24225667
[TBL] [Abstract][Full Text] [Related]
17. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
18. Copper Complexes in Cancer Therapy.
Denoyer D; Clatworthy SAS; Cater MA
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394035
[TBL] [Abstract][Full Text] [Related]
19. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
[TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead.
Wang Y; He QY; Sun RW; Che CM; Chiu JF
Eur J Pharmacol; 2007 Jan; 554(2-3):113-22. PubMed ID: 17116302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
